Skip to main content

Table 2 Patient Demographics and Study Eye Characteristics of Patients with Central Retinal Vein Occlusion associated Cystoid Macular Oedema that were enrolled into the study

From: A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study

Characteristic

 Eye, n (%)

  Right

12 (60%)

  Left

8 (40%)

 Age, years

  Mean ± SD

61.8 ± 14.3

  Range

23 to 84

 Gender, n (%)

  Male

16 (80%)

  Female

4 (20%)

 Hypertension, n (%)

  Yes

10 (50%)

  No

10 (50%)

 Diabetes, n (%)

  Yes

7 (35%)

  No

13 (65%)

 Hypercholesterolemia, n (%)

  Yes

4 (20%)

  No

16 (80%)

 BCVA, ETDRS letter

  Median [interquartile range]

55.0 [36.8 to 64.8]

  Range

20.0 to 70.0

   > 20/200

15 (75%)

 CMT, μm

  Mean ± SD

807 ± 238

  Range

354 to 1281

 IOP, mmHg

  Mean ± SD

14.3 ± 2.6

 Perfusion status, n (%)

  Perfused

10 (50%)

  Non-perfused

5 (25%)

  Indeterminate

5 (25%)

  1. SD standard deviation, BCVA best-correct visual acuity, ETDRS Early Treatment of Diabetic Retinopathy Study, CMT central macular thickness, IOP intraocular pressure